Annals of Oncology 2007 Sep;18(9):1529-38.
A phase II study of epigenetic therapy with hydralazine and
magnesium valproate to overcome chemotherapy resistance in
refractory solid tumors.;Candelaria M, Gallardo-Rincon D, Arce C,
Cetina L, Aguilar-Ponce J, Arrieta O, Gonzalez-Fierro A,
Chavez-Blanco A, de la Cruz-Hernandez E, Camargo M, Trejo-Becerril
C, Perez-Cardenas E, Perez-Plasencia C, Taja-Chayeb L,
Wegman-Ostrosky T, Revilla-Vazquez A, Duenas-Gonzalez A.
Unidad de Investigacion Biomedica en Cancer, Instituto de
Investigaciones Biomedicas (IIB), Universidad Nacional Autonoma de
Mexico (UNAM), Instituto Nacional de Cancerologia, Mexico City.
May God bless you!
전성수 |